Search results
Local Archives
Metro Weekly· 10 minutes agoDoctors, researchers and HIV/AIDS experts from Washington presented information about the epidemic within the D.C. to AIDS 2012 delegates yesterday, July 25, explaining how the...
Appeals court finds 'Obamacare' pillar unconstitutional in suit over HIV-prevention drug
NBC Universal via AOL· 18 hours agoWhether insurance companies would cover a drug costing far more than generic Truvada without a legal...
Americans with HIV are living longer. Federal spending isn’t keeping up
Sun-Sentinel· 20 hours agoMalcolm Reid recently marked the anniversary of his HIV diagnosis on Facebook. “Diagnosed with HIV...
Common Misconceptions about HIV
News Channel 5 Nashville· 2 days agoOn this episode of MorningLine, Nick Beres is joined by Nashville CARES CEO, Amna Osman, to discuss how her organization is working to end the HIV/AIDS ...
Forty years ago, AIDS was a death sentence. Not today, but HIV is still a health threat
The Commercial Appeal via Yahoo News· 3 days agoThe researcher said this “worrisome trend” points to an urgent need for better prevention strategies...
Local CEO has made a career of stopping disease in its tracks - Boston Business Journal
The Business Journals· 2 days agoThe Business Journal spoke with Emini about his transformative work at Gates MRI, his decades-long...
Gilead surges as HIV prevention therapy shows 100% efficacy in late-stage trial By Proactive...
Investing.com· 2 days agoGilead Sciences Inc (NASDAQ:GILD, ETR:GIS) shares added more than 8% after the pharmaceutical firm...
Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial
CNBC· 2 days agoGilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial,...
Dr. Anthony Fauci's 'Brooklyn Tough' Attitude Got Tested Early On: Read an Excerpt from His New...
People via Yahoo News· 4 days agoThe Brooklyn-born doctor, 83, served as the director of the National Institute of ...Infectious...
Gilead's twice-a-year HIV PrEP drug delivers stunning results in late-stage study - San Francisco...
The Business Journals· 2 days agoInjected only twice a year, an HIV PrEP drug developed by Gilead Sciences Inc. showed zero...
